Taysha Gene Therapies Inc Earnings

The next earnings date for Taysha Gene Therapies Inc is November 13, 2025.

They are scheduled to announce earnings before the market opens that day.

Analyst Estimates of Taysha Gene Therapies Inc Earnings

Report DateEstimated Earnings Per Share
11/13/2025$-0.08

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Taysha Gene Therapies Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/29/2025After Market$-0.0717.11%
03/17/2025Before Market$-0.0715.36%
11/12/2024Before Market$-0.0720.89%
08/12/2024Before Market$-0.0943.75%
05/14/2024After Market$-0.109.09%
03/19/2024After Market$0.92936.36%
11/14/2023After Market$-0.1323.53%
08/14/2023Before Market$-0.38-22.58%
05/11/2023After Market$-0.2820.00%
03/28/2023After Market$-0.99-200.00%
11/08/2022Before Market$-0.6421.95%
08/11/2022Before Market$-0.8416.00%
05/16/2022Before Market$-1.31-22.43%
03/31/2022Before Market$-1.32-5.60%
11/10/2021Before Market$-1.35-25.00%
08/16/2021Before Market$-1.09-29.76%
05/11/2021Before Market$-0.87-55.36%
03/03/2021Before Market$-1.04-181.08%
11/12/2020After Market$-1.28-652.94%
09/25/2020After Market$-1.28---

More About Taysha Gene Therapies Inc

Country
USA
Full Time Employees
73

Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. The company has research, collaboration, and license agreement with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.

Taysha Gene Therapies Inc Earnings” Can Refer to the Taysha Gene Therapies Inc Earnings Date

Some people say “Taysha Gene Therapies Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Taysha Gene Therapies Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Taysha Gene Therapies Inc Stock on the Earnings Date

If you own Taysha Gene Therapies Inc stock (TSHA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Taysha Gene Therapies Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Taysha Gene Therapies Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Taysha Gene Therapies Inc Earnings

You can contact us any time if you would like to ask questions about Taysha Gene Therapies Inc earnings or anything else related to the stock market.